| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | -79.2% |
| Gross profit | ¥-0.23B | — |
| Operating income | ¥-0.96B | — |
| Net income | ¥-0.80B | — |
| Gross margin | -120.8% | Net margin -424.8% |
| Revenue Q/Q | -88.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.42B | 220.8% |
| R&D | ¥0.01B | 2.9% |
| SG&A | ¥0.06B | 30.1% |
| Tax & other | ¥-0.16B | -82.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华润微 ・ 阿特斯 ・ 百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies